Do analysts prefer SYNT or SCPA?

Synthomer presently has a consensus price target of GBX 119, indicating a potential upside of 20.20%. Given Synthomer's stronger consensus rating and higher possible upside, research analysts plainly believe Synthomer is more favorable than Scapa Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synthomer 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, SYNT or ZTF?

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.80B 0.09 -£82.04M -£96.00 N/A Zotefoams £176.29M 1.24 £9.80M £44.87 9.91

Is SYNT or ZTF more profitable?

Zotefoams has a net margin of 13.88% compared to Synthomer's net margin of -6.81%. Zotefoams' return on equity of 18.18% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -6.81% -13.27% -0.28% Zotefoams 13.88% 18.18% 5.48%

Does the media prefer SYNT or ZTF?

In the previous week, Zotefoams had 5 more articles in the media than Synthomer. MarketBeat recorded 6 mentions for Zotefoams and 1 mentions for Synthomer. Zotefoams' average media sentiment score of 0.98 beat Synthomer's score of 0.22 indicating that Zotefoams is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synthomer 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zotefoams 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, TET or SYNT?

Treatt has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Treatt £128.29M 1.40 £11.22M £7.22 42.24 Synthomer £1.80B 0.09 -£82.04M -£96.00 N/A

Is TET or SYNT more profitable?

Treatt has a net margin of 3.40% compared to Synthomer's net margin of -6.81%. Treatt's return on equity of 3.22% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Treatt 3.40% 3.22% 6.72% Synthomer -6.81% -13.27% -0.28%

Which has better valuation and earnings, SYNT or IOF?

Iofina has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.80B 0.09 -£82.04M -£96.00 N/A Iofina £66.52M 1.53 £4.28M £4.00 13.25

Is SYNT or IOF more profitable?

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -6.81%. Iofina's return on equity of 14.89% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -6.81% -13.27% -0.28% Iofina 11.84% 14.89% 5.18%

Does the media refer more to SYNT or IOF?

In the previous week, Synthomer and Synthomer both had 1 articles in the media. Iofina's average media sentiment score of 1.43 beat Synthomer's score of 0.22 indicating that Iofina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synthomer 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Iofina 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer HDD or SYNT?

Synthomer has a consensus target price of GBX 119, indicating a potential upside of 20.20%. Given Synthomer's stronger consensus rating and higher possible upside, analysts plainly believe Synthomer is more favorable than Hardide. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hardide 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Synthomer 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has higher earnings and valuation, HDD or SYNT?

Hardide has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hardide £8.02M 8.06 -£1.89M £1.80 45.56 Synthomer £1.80B 0.09 -£82.04M -£96.00 N/A

Is HDD or SYNT more profitable?

Hardide has a net margin of 15.60% compared to Synthomer's net margin of -6.81%. Hardide's return on equity of 32.49% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Hardide 15.60% 32.49% -9.80% Synthomer -6.81% -13.27% -0.28%

Does the media prefer HDD or SYNT?

In the previous week, Hardide and Hardide both had 1 articles in the media. Hardide's average media sentiment score of 0.89 beat Synthomer's score of 0.22 indicating that Hardide is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hardide 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Synthomer 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Synthomer (SYNT) Competitors

GBX 99 -2.20 (-2.17%)

As of 12:38 PM Eastern

Compare

SYNT vs. SCPA, ZTF, TET, IOF, and HDD

Should you buy Synthomer stock or one of its competitors? Synthomer's main competitors and comparable companies include Scapa Group (SCPA), Zotefoams (ZTF), Treatt (TET), Iofina (IOF), and Hardide (HDD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "specialty chemicals" industry.

How does Synthomer compare to Scapa Group?

Synthomer (LON:SYNT) and Scapa Group (LON:SCPA) are both small-cap materials companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Synthomer presently has a consensus price target of GBX 119, indicating a potential upside of 20.20%. Given Synthomer's stronger consensus rating and higher possible upside, research analysts plainly believe Synthomer is more favorable than Scapa Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Scapa Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Synthomer had 1 more articles in the media than Scapa Group. MarketBeat recorded 1 mentions for Synthomer and 0 mentions for Scapa Group. Synthomer's average media sentiment score of 0.22 beat Scapa Group's score of 0.00 indicating that Synthomer is being referred to more favorably in the media.

Company	Overall Sentiment
Synthomer	Neutral
Scapa Group	Neutral

14.9% of Synthomer shares are owned by institutional investors. 5.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Scapa Group has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Scapa Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.80B	0.09	-£82.04M	-£96.00	N/A
Scapa Group	£281.80M	0.00	N/A	-£29.30	N/A

Scapa Group has a net margin of 0.00% compared to Synthomer's net margin of -6.81%. Scapa Group's return on equity of 0.00% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-6.81%	-13.27%	-0.28%
Scapa Group	N/A	N/A	N/A

Summary

Synthomer beats Scapa Group on 9 of the 13 factors compared between the two stocks.

How does Synthomer compare to Zotefoams?

Synthomer (LON:SYNT) and Zotefoams (LON:ZTF) are both small-cap materials companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

In the previous week, Zotefoams had 5 more articles in the media than Synthomer. MarketBeat recorded 6 mentions for Zotefoams and 1 mentions for Synthomer. Zotefoams' average media sentiment score of 0.98 beat Synthomer's score of 0.22 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Synthomer	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Zotefoams	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.80B	0.09	-£82.04M	-£96.00	N/A
Zotefoams	£176.29M	1.24	£9.80M	£44.87	9.91

Synthomer currently has a consensus target price of GBX 119, indicating a potential upside of 20.20%. Zotefoams has a consensus target price of GBX 605, indicating a potential upside of 36.04%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts plainly believe Zotefoams is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

14.9% of Synthomer shares are held by institutional investors. Comparatively, 28.9% of Zotefoams shares are held by institutional investors. 5.0% of Synthomer shares are held by company insiders. Comparatively, 4.5% of Zotefoams shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Synthomer has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Zotefoams has a beta of 1.243, meaning that its share price is 24% more volatile than the broader market.

Zotefoams has a net margin of 13.88% compared to Synthomer's net margin of -6.81%. Zotefoams' return on equity of 18.18% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-6.81%	-13.27%	-0.28%
Zotefoams	13.88%	18.18%	5.48%

Summary

Zotefoams beats Synthomer on 14 of the 16 factors compared between the two stocks.

How does Synthomer compare to Treatt?

Treatt (LON:TET) and Synthomer (LON:SYNT) are both small-cap materials companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

Treatt has a beta of 0.907, meaning that its stock price is 9% less volatile than the broader market. Comparatively, Synthomer has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

In the previous week, Synthomer had 1 more articles in the media than Treatt. MarketBeat recorded 1 mentions for Synthomer and 0 mentions for Treatt. Synthomer's average media sentiment score of 0.22 beat Treatt's score of 0.00 indicating that Synthomer is being referred to more favorably in the news media.

Company	Overall Sentiment
Treatt	Neutral
Synthomer	Neutral

Treatt currently has a consensus price target of GBX 248.33, indicating a potential downside of 18.58%. Synthomer has a consensus price target of GBX 119, indicating a potential upside of 20.20%. Given Synthomer's higher probable upside, analysts clearly believe Synthomer is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

17.5% of Treatt shares are owned by institutional investors. Comparatively, 14.9% of Synthomer shares are owned by institutional investors. 4.1% of Treatt shares are owned by company insiders. Comparatively, 5.0% of Synthomer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Treatt has a net margin of 3.40% compared to Synthomer's net margin of -6.81%. Treatt's return on equity of 3.22% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treatt	3.40%	3.22%	6.72%
Synthomer	-6.81%	-13.27%	-0.28%

Treatt has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treatt	£128.29M	1.40	£11.22M	£7.22	42.24
Synthomer	£1.80B	0.09	-£82.04M	-£96.00	N/A

Summary

Treatt beats Synthomer on 9 of the 15 factors compared between the two stocks.

How does Synthomer compare to Iofina?

Synthomer (LON:SYNT) and Iofina (LON:IOF) are both small-cap materials companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

Iofina has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.80B	0.09	-£82.04M	-£96.00	N/A
Iofina	£66.52M	1.53	£4.28M	£4.00	13.25

14.9% of Synthomer shares are owned by institutional investors. Comparatively, 1.5% of Iofina shares are owned by institutional investors. 5.0% of Synthomer shares are owned by company insiders. Comparatively, 13.4% of Iofina shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -6.81%. Iofina's return on equity of 14.89% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-6.81%	-13.27%	-0.28%
Iofina	11.84%	14.89%	5.18%

In the previous week, Synthomer and Synthomer both had 1 articles in the media. Iofina's average media sentiment score of 1.43 beat Synthomer's score of 0.22 indicating that Iofina is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Synthomer	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Iofina	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Synthomer has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Iofina has a beta of 0.883, suggesting that its stock price is 12% less volatile than the broader market.

Synthomer presently has a consensus price target of GBX 119, suggesting a potential upside of 20.20%. Iofina has a consensus price target of GBX 65, suggesting a potential upside of 22.64%. Given Iofina's stronger consensus rating and higher possible upside, analysts plainly believe Iofina is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Iofina beats Synthomer on 11 of the 14 factors compared between the two stocks.

How does Synthomer compare to Hardide?

Hardide (LON:HDD) and Synthomer (LON:SYNT) are both small-cap materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

10.2% of Hardide shares are owned by institutional investors. Comparatively, 14.9% of Synthomer shares are owned by institutional investors. 65.7% of Hardide shares are owned by insiders. Comparatively, 5.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Hardide has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hardide	£8.02M	8.06	-£1.89M	£1.80	45.56
Synthomer	£1.80B	0.09	-£82.04M	-£96.00	N/A

Synthomer has a consensus target price of GBX 119, indicating a potential upside of 20.20%. Given Synthomer's stronger consensus rating and higher possible upside, analysts plainly believe Synthomer is more favorable than Hardide.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hardide	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Hardide and Hardide both had 1 articles in the media. Hardide's average media sentiment score of 0.89 beat Synthomer's score of 0.22 indicating that Hardide is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hardide	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Synthomer	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Hardide has a net margin of 15.60% compared to Synthomer's net margin of -6.81%. Hardide's return on equity of 32.49% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hardide	15.60%	32.49%	-9.80%
Synthomer	-6.81%	-13.27%	-0.28%

Hardide has a beta of 1.163, meaning that its share price is 16% more volatile than the broader market. Comparatively, Synthomer has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

Summary

Hardide beats Synthomer on 9 of the 15 factors compared between the two stocks.

Get Synthomer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SYNT vs. The Competition

Export

Metric	Synthomer	Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£162.31M	£11.33B	£4.85B	£2.88B
Dividend Yield	28.47%	2.84%	4.71%	6.10%
P/E Ratio	-1.03	41.72	25.19	368.46
Price / Sales	0.09	46.03	4,706.33	83,426.45
Price / Cash	2.28	15.51	24.65	27.89
Price / Book	0.15	3.59	8.87	7.08
Net Income	-£82.04M	£222.46M	£154.79M	£5.89B
7 Day Performance	-11.92%	-0.08%	0.38%	0.54%
1 Month Performance	20.73%	2.80%	9.03%	3.02%
1 Year Performance	45.59%	19.33%	43.81%	64.50%

Synthomer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SYNT Synthomer	2.2108 of 5 stars	GBX 99 -2.2%	GBX 119 +20.2%	+48.8%	£162.31M	£1.80B	N/A	4,200
SCPA Scapa Group	N/A	N/A	N/A	N/A	£402.98M	£281.80M	N/A	1,461
ZTF Zotefoams	4.7701 of 5 stars	GBX 428 -2.5%	GBX 605 +41.4%	+3.3%	£210.50M	£176.29M	9.54	549	Insider Trade
TET Treatt	N/A	GBX 305 flat	GBX 248.33 -18.6%	N/A	£180.06M	£128.29M	42.24	350
IOF Iofina	3.7705 of 5 stars	GBX 52.10 -0.8%	GBX 65 +24.8%	+104.7%	£99.96M	£66.52M	13.03	95	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:SYNT) was last updated on 8/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synthomer (SYNT) Competitors

SYNT vs. SCPA, ZTF, TET, IOF, and HDD

How does Synthomer compare to Scapa Group?

Summary

How does Synthomer compare to Zotefoams?

Summary

How does Synthomer compare to Treatt?

Summary

How does Synthomer compare to Iofina?

Summary

How does Synthomer compare to Hardide?

Summary

Media Sentiment Over Time

SYNT vs. The Competition

Synthomer Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synthomer (SYNT) Competitors

SYNT vs. SCPA, ZTF, TET, IOF, and HDD

How does Synthomer compare to Scapa Group?

Do analysts prefer SYNT or SCPA?

Does the media favor SYNT or SCPA?

Do institutionals and insiders believe in SYNT or SCPA?

Which has preferable earnings and valuation, SYNT or SCPA?

Is SYNT or SCPA more profitable?

Summary

How does Synthomer compare to Zotefoams?

Does the media prefer SYNT or ZTF?

Which has higher valuation and earnings, SYNT or ZTF?

Do analysts recommend SYNT or ZTF?

Do insiders and institutionals hold more shares of SYNT or ZTF?

Which has more volatility and risk, SYNT or ZTF?

Is SYNT or ZTF more profitable?

Summary

How does Synthomer compare to Treatt?

Which has more volatility & risk, TET or SYNT?

Does the media prefer TET or SYNT?

Do analysts recommend TET or SYNT?

Do institutionals and insiders believe in TET or SYNT?

Is TET or SYNT more profitable?

Which has stronger valuation & earnings, TET or SYNT?

Summary

How does Synthomer compare to Iofina?

Which has better valuation and earnings, SYNT or IOF?

Do institutionals and insiders hold more shares of SYNT or IOF?

Is SYNT or IOF more profitable?

Does the media refer more to SYNT or IOF?

Which has more risk & volatility, SYNT or IOF?

Do analysts recommend SYNT or IOF?

Summary

How does Synthomer compare to Hardide?

Do insiders & institutionals have more ownership in HDD or SYNT?

Which has higher earnings and valuation, HDD or SYNT?

Do analysts prefer HDD or SYNT?

Does the media prefer HDD or SYNT?

Is HDD or SYNT more profitable?

Which has more volatility and risk, HDD or SYNT?

Summary

Media Sentiment Over Time

SYNT vs. The Competition

Synthomer Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools